CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
出版年份 2019 全文链接
标题
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
作者
关键词
Hepatocellular carcinoma, CD73, Epithelial-mesenchymal-transition, Prognosis, PI3K/AKT
出版物
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-04-11
DOI
10.1186/s13045-019-0724-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- In Vivo Labeling by CD73 Marks Multipotent Stromal Cells and Highlights Endothelial Heterogeneity in the Bone Marrow Niche
- (2018) Martin Breitbach et al. Cell Stem Cell
- Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
- (2018) Wei Guo et al. CLINICAL CANCER RESEARCH
- Exosomal miRNAs in hepatocellular carcinoma development and clinical responses
- (2018) Shuangshuang Li et al. Journal of Hematology & Oncology
- miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
- (2018) Man-Qing Cao et al. Journal of Hematology & Oncology
- New trials and results in systemic treatment of HCC
- (2018) María Reig et al. JOURNAL OF HEPATOLOGY
- Ras and Rap1: A tale of two GTPases
- (2018) Seema Shah et al. SEMINARS IN CANCER BIOLOGY
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
- (2018) Theresa Kordaß et al. Frontiers in Immunology
- Abstract 3604: Centrosome amplification in epcam-captured circulating tumor cells from metastatic cancer patients
- (2018) Ashok Singh et al. CANCER RESEARCH
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Ecto-5′-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
- (2018) Shalaimaiti Shali et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Extracellular 5′-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway
- (2017) Jiangang Yu et al. INTERNATIONAL JOURNAL OF CANCER
- The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
- (2017) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Ubc9 Binds to ADAP and Is Required for Rap1 Membrane Recruitment, Rac1 Activation, and Integrin-Mediated T Cell Adhesion
- (2017) Yiwei Xiong et al. JOURNAL OF IMMUNOLOGY
- Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
- (2017) Xiaoqi Huo et al. Molecular Cancer
- CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
- (2017) Jianjie Zhu et al. Molecular Cancer
- Recent advances in hepatocellular carcinoma therapy
- (2017) Rinku Dutta et al. PHARMACOLOGY & THERAPEUTICS
- Prospectively isolated mesenchymal stem/stromal cells are enriched in the CD73+ population and exhibit efficacy after transplantation
- (2017) Eriko Grace Suto et al. Scientific Reports
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
- (2016) Shao-Lai Zhou et al. HEPATOLOGY
- CD73–adenosine: a next-generation target in immuno-oncology
- (2016) David Allard et al. Immunotherapy
- Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
- (2016) Aparna Jayachandran et al. Journal of Hematology & Oncology
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
- (2013) R. Wei et al. CLINICAL CANCER RESEARCH
- Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
- (2013) B. Allard et al. CLINICAL CANCER RESEARCH
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways
- (2013) Yasuhito Onodera et al. JOURNAL OF CLINICAL INVESTIGATION
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- Rap1, a mercenary among the Ras-like GTPases
- (2010) E.W. Frische et al. DEVELOPMENTAL BIOLOGY
- A Rap/Phosphatidylinositol 3-Kinase Pathway Controls Pseudopod Formation
- (2010) Arjan Kortholt et al. MOLECULAR BIOLOGY OF THE CELL
- Chemoattractant-mediated Rap1 activation requires GPCR/G proteins
- (2010) Injun Cha et al. MOLECULES AND CELLS
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started